epidermal-growth-factor and Neonatal-Sepsis

epidermal-growth-factor has been researched along with Neonatal-Sepsis* in 1 studies

Other Studies

1 other study(ies) available for epidermal-growth-factor and Neonatal-Sepsis

ArticleYear
Maternal activation of the EGFR prevents translocation of gut-residing pathogenic
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 04-07, Volume: 117, Issue:14

    Late-onset sepsis (LOS) is a highly consequential complication of preterm birth and is defined by a positive blood culture obtained after 72 h of age. The causative bacteria can be found in patients' intestinal tracts days before dissemination, and cohort studies suggest reduced LOS risk in breastfed preterm infants through unknown mechanisms. Reduced concentrations of epidermal growth factor (EGF) of maternal origin within the intestinal tract of mice correlated to the translocation of a gut-resident human pathogen

    Topics: Animals; Animals, Newborn; Antigens, Bacterial; Bacterial Translocation; Breast Feeding; Colon; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors; Escherichia coli; Escherichia coli Infections; Feces; Female; Gastrointestinal Microbiome; Humans; Infant, Newborn; Infant, Premature; Intestinal Mucosa; Male; Mice; Mice, Transgenic; Milk, Human; Neonatal Sepsis; Signal Transduction; Time Factors

2020